To view this email as a web page, click here.
 
ONCOLOGY | September 23, 2019
 
ONCOLOGY: Practical, Peer-Reviewed Perspectives
ONCOLOGY: Practical, Peer-Reviewed Perspectives
Volume 33, Number 9
Click here to view the full table of contents
Click here to view the digital edition
 
Insights from an Oncology Pharmacist
 
Insights from an Oncology Pharmacist: Venetoclax
Kelly Valla, PharmD, BCOP
With FDA-approved indications for both chronic lymphocytic leukemia and acute myeloid leukemia, and continued investigation within multiple disease states, venetoclax has become an exciting oral targeted therapy among oncologists.
Read more
 
LUNG CANCER
 
Drugs in the Pipeline: Non-Small-Cell Lung Cancer
Naveed Saleh, MD, MS
Several promising drugs for the treatment of lung cancer have been garnering attention over recent years. These new treatments have been highlighted at conferences and are sure to impact the standard of care.
Read more
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.